IBC Life Sciences, Hilton Logan Airport, Boston, MA
June 23-25, 2004
IBC’s Second Annual Inflammatory Diseases conference addresses therapeutic research and development advances impacting arthritis, pulmonary diseases, psoriasis, and other inflammatory conditions, with a focus on rheumatoid arthritis and asthma – diseases with significant resources dedicated to discovery research. The conference programming will look at how targets for these major research areas are being utilized for new anti-inflammatory therapies to combat multiple inflammation-related conditions. This conference will allow you to track the progress of the leaders in this market segment and make research contacts that will improve and accelerate your product pipelines. Plus, attend a full-day pre-conference symposium on Targeting and Control of Innate Immunity to learn about novel therapeutics based on toll-like receptors and how research in this field is revealing new methods to control the innate immune response. For up-to-date information on this event and to register online, visit www.LifeSciencesInfo.com/inflammation.
|
|